FamiCord AG (ETR:V3V)

Market Cap	51.25M -53.3%
Revenue (ttm)	87.78M +0.1%
Net Income	-7.52M
EPS	-0.43
Shares Out	17.43M
PE Ratio	n/a
Forward PE	294.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12
Open	2.940
Previous Close	2.940
Day's Range	2.940 - 2.940
52-Week Range	2.580 - 7.150
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About FamiCord AG

FamiCord AG engages in the collection, processing, storage, and distribution of cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally. The company operates through Subgroup Vita 34 And Subgroup PBKM segments. It produces and develops advanced therapies, genetic tests, and analyses for third parties. The company also engages in the development and manufacture of cell and tissue-based products and pharmaceuticals, including the production of viral vectors or comparable ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1997
• Employees: 723
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: V3V

Financial Performance

In 2025, FamiCord AG's revenue was 88.17 million, an increase of 7.29% compared to the previous year's 82.18 million. Losses were -6.30 million, -48.06% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 16, 2026

Data Sources Report a data error